866-997-4948(US-Canada Toll Free)

Global Needle-Free Drug Delivery Market 2017-2021

Published By :

Technavio

Published Date : Jun 2017

Category :

Orthopedics

No. of Pages : 70 Pages

About Needle Free Drug Delivery

Needle free drug delivery technologies are used to deliver biologics such as insulin, vaccines, human growth hormone (HGH), and drugs for pain management into the patients body without using a traditional needle. Needle free drug delivery market includes jet injectors, transdermal drug delivery systems and other novel needle free devices that are used as alternatives to conventional needle drug delivery devices.

Technavios analysts forecast the global needle free drug delivery market to grow at a CAGR of 10.31% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global needle free drug delivery market for 2017-2021. To calculate the market size, the report considers sales and value.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Needle Free Drug Delivery Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Endo Pharmaceuticals
Antares Pharma
Inovio Pharmaceuticals
Valeritas
PharmaJet

Other prominent vendors
3M
Akra Dermojet
Consort Medical
CROSSJECT
Injex Pharma (acquired by Hangzhou Hema Medical Equipment)
PenJet Corporation
Zosano
DAntonio Consultants International
European Pharma Group

Market driver
Increasing incidence of needle stick injuries
For a full, detailed list, view our report

Market challenge
Technical complexities of needle free drug delivery devices
For a full, detailed list, view our report

Market trend
Increasing outsourcing
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.




Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
Market outline
PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 06: Market segmentation by product/technology
Jet injectors
Market size and forecast
Transdermal drug delivery systems
Market size and forecast
Others
Market size and forecast
PART 07: Market segmentation by application
Market segmentation by application
Insulin delivery
Vaccination
Pain management
Others
PART 08: Geographical segmentation
Market overview
Americas
EMEA
APAC
PART 09: Decision framework
PART 10: Drivers and challenges
Market drivers
Market challenges
PART 11: Market trends
Technological innovations
Increasing outsourcing
M&A and strategic collaborations
PART 12: Vendor landscape
Competitive scenario
PART 13: Key vendor analysis
Endo Pharmaceuticals
Antares Pharma
Inovio Pharmaceuticals
Valeritas
PharmaJet
Other prominent vendors
PART 14: Appendix
List of abbreviations
List of Exhibits
Exhibit 01: Global needle free drug delivery market: Segmentation overview
Exhibit 02: Global needle free drug delivery market 2016-2021 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Global needle free drug delivery market by product/technology
Exhibit 05: Global needle free drug delivery market share by product/technology 2016 (%)
Exhibit 06: Jet injectors in market
Exhibit 07: Jet injectors in development
Exhibit 08: Global jet injectors market 2016-2021: Overview
Exhibit 09: Global jet injectors market 2016-2021 ($ billions)
Exhibit 10: Microneedle drug delivery systems in market
Exhibit 11: Microneedle drug delivery systems in development
Exhibit 12: Iontophoresis drug delivery systems in market
Exhibit 13: Global transdermal drug delivery systems market 2016-2021: Overview
Exhibit 14: Global transdermal needle free drug delivery systems market 2016-2021 ($ billions)
Exhibit 15: Other drug delivery systems in market
Exhibit 16: Global other needle free drug delivery devices market 2016-2021 ($ billions)
Exhibit 17: Global needle free drug delivery market by application
Exhibit 18: Global needle free drug delivery market share by application 2016 (%)
Exhibit 19: Needle free insulin delivery systems in market
Exhibit 20: Needle free insulin delivery systems in development
Exhibit 21: Needle free vaccine delivery systems in market
Exhibit 22: Needle free vaccine delivery systems in development
Exhibit 23: Global needle free drug delivery market by geography 2016 (%)
Exhibit 24: Needle free drug delivery market in Americas 2016-2021 ($ billions)
Exhibit 25: Needle free drug delivery market in EMEA 2016-2021 ($ billions)
Exhibit 26: Needle free drug delivery market in APAC 2016-2021 ($ billions)
Exhibit 27: Endo International: Key highlights
Exhibit 28: Endo International: Strength assessment
Exhibit 29: Endo International: Strategy assessment
Exhibit 30: Endo International: Opportunity assessment
Exhibit 31: Antares Pharma: Key highlights
Exhibit 32: Antares Pharma: Strength assessment
Exhibit 33: Antares Pharma: Strategy assessment
Exhibit 34: Antares Pharma: Opportunity assessment
Exhibit 35: Inovio Pharmaceuticals: Key highlights
Exhibit 36: Inovio Pharmaceuticals: Strength assessment
Exhibit 37: Inovio Pharmaceuticals: Strategy assessment
Exhibit 38: Inovio Pharmaceuticals: Opportunity assessment
Exhibit 39: Valeritas: Key highlights
Exhibit 40: Valeritas: Strength assessment
Exhibit 41: Valeritas: Strategy assessment
Exhibit 42: Valeritas: Opportunity assessment
Exhibit 43: PharmaJet: Key highlights
Exhibit 44: PharmaJet: Strength assessment
Exhibit 45: PharmaJet: Strategy assessment
Exhibit 46: PharmaJet: Opportunity assessment

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *